journal article·2026-05

Advancement in fabricating precision hemostats using nanocomposites and polymeric systems: From biofunctionality to clinical translation

Ankit Majie, Santanu Ghosh, Bapi Gorain

Publisher page

Abstract

The ever-increasing challenge of tackling traumatic injuries urges newer hemostatic technologies with rapid hemorrhagic control and improved wound healing to overcome the limitations of conventional gauze and dressings, used for emergency trauma control. With this aim, the current review focuses on nanocomposites, biopolymeric, and synthetic systems, as well as their complex combinations that incorporate different bioactive nanomaterials into either naturally derived or synthetic polymeric matrices. These nanoscale particles are providing an increased surface area for their bioactivity and improved drug-loading capacity. Additionally, advanced polymeric materials, such as hydrogels, gauzes, microspheres, nanofibers, sponges, and foams, are currently loaded with these nanoparticles to enhance their properties, including improved swellability, porosity, and adsorption. These advanced formulations primarily restrict blood flow by providing a physical barrier, followed by the absorption of platelets and RBCs onto their structural scaffold due to the modulation of their surface charge, imparted by various functional groups. Furthermore, highly porous matrices are known to absorb fluid and concentrate blood cells at the wound surface, inducing the formation of a firm and stable blood clot. Consequently, the nanoparticles released from the polymeric matrices induce several molecular effects to accelerate wound closure.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Hemostasis and retained surgical items · Wound Healing and Treatments · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Trauma-induced coagulopathy10.1038/s41572-021-00264-3 ↗
2. Modern management of bleeding, clotting, and coagulopathy in trauma patients: what is the role of viscoelastic assays?10.1007/s40719-020-00183-w ↗
3. Epidemiology of trauma-related hemorrhage and time to definitive care across North America: making the case for bleeding control education10.1017/S1049023X23006428 ↗
4. Jucá Moscardi · 2020 · 5
5. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the resuscitation outcomes consortium10.1097/SLA.0000000000000837 ↗
6. Epidemiology of traumatic deaths: comprehensive population-based assessment10.1007/s00268-009-0266-1 ↗
7. A comparison of initial lactate and initial base deficit as predictors of mortality after severe blunt trauma10.1016/j.jss.2016.06.103 ↗
8. Platelets and their role in hemostasis and thrombosis—from physiology to pathophysiology and therapeutic implications10.3390/ijms232112772 ↗
9. Molecular insights into the relationship between platelet activation and endothelial dysfunction: molecular approaches and clinical practice10.1007/s12033-023-01010-8 ↗
10. Thrombin in the crossroad hemostasis and inflammation10.1134/S0022093023050216 ↗
11. Platelet biology and receptor pathways10.1007/s12265-012-9445-9 ↗
12. Icaritin sensitizes thrombin- and TxA2-induced platelet activation and promotes hemostasis via enhancing PLCγ2-PKC signaling pathways10.1055/a-2245-8457 ↗
13. How it all starts: initiation of the clotting cascade10.3109/10409238.2015.1050550 ↗
14. The coagulopathy of trauma: a review of mechanisms10.1097/TA.0b013e3181877a9c ↗
15. Acute traumatic coagulopathy and trauma-induced coagulopathy: an overview10.1186/s40560-016-0196-6 ↗
16. Physiology of haemostasis10.1016/j.mpaic.2024.09.015 ↗
17. Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis10.1007/s10787-024-01629-2 ↗
18. Chitosan hemostatic dressings: properties and Surgical applications10.3390/polym16131770 ↗
19. Hemostasis strategies and recent advances in hydrogels for managing uncontrolled hemorrhage10.1021/acsabm.4c01221 ↗
20. Development of silk fibroin-based non-crosslinking thermosensitive bioinks for 3D bioprinting10.3390/polym15173567 ↗
21. Nanocomposite sponge based on sodium alginate, polyvinyl alcohol, carbon dots, and woolly hedge nettle antibacterial extract for wound healing10.1016/j.indcrop.2024.118554 ↗
22. Dual-sided and flexible triboelectric nanogenerator-based hydrogel skin patch for promoting wound healing10.1016/j.nanoen.2024.110558 ↗
23. Gelatin/calcium chloride electrospun nanofibers for rapid hemostasis10.1039/D2BM01767A ↗
24. Hemostatic biomaterials to halt non-compressible hemorrhage10.1039/D2TB00546H ↗
25. Surface-functionalized design of blood-contacting biomaterials for preventing coagulation and promoting hemostasis10.1007/s40544-022-0710-x ↗
26. Inorganic-based biomaterials for rapid hemostasis and wound healing10.1039/D2SC04962G ↗
27. Advances in the development and optimization strategies of the hemostatic biomaterials10.3389/fbioe.2022.1062676 ↗
28. Engineered hemostatic biomaterials for sealing wounds10.1021/acs.chemrev.1c01015 ↗
29. Advances in the development of hemostatic biomaterials for medical application10.1186/s40824-021-00239-1 ↗
30. Advances of biological macromolecules hemostatic materials: a review10.1016/j.ijbiomac.2024.131772 ↗
31. Recent advances in biopolymer-based hemostatic materials10.1093/rb/rbac063 ↗
32. The role of nanoscale structures in the development of topical hemostatic agents
33. Hemostatic nanotechnologies for external and internal hemorrhage management10.1039/D0BM00781A ↗
34. Research status and development potential of composite hemostatic materials10.1039/D0TB00906G ↗
35. The next frontier in hemorrhagic management: a comprehensive review on development of natural polymer-based injectable hydrogels as promising hemostatic dressings10.1016/j.cej.2024.155033 ↗
36. Current and future prospects of injectable smart hydrogels
37. Review of new topical hemostatic dressings for combat casualty care10.7205/MILMED-D-13-00199 ↗
38. Recent advances in biopolymer-based hemostatic materials10.1093/rb/rbac063 ↗
39. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation10.1016/0049-3848(94)90227-5 ↗
40. Fibrin sealant: past, present, and future: a brief review10.1007/s00268-009-0252-7 ↗
41. A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of γ chains by factor XIIIa10.1073/pnas.95.2.537 ↗
42. Crystal structure of fragment double-D from human fibrin with two different bound ligands10.1021/bi9804129 ↗
43. Modulation of fibrin matrix properties via knob:hole affinity interactions using peptide–PEG conjugates10.1016/j.biomaterials.2011.02.050 ↗
44. Peptide optimization and conjugation strategies in the development of molecularly targeted magnetic resonance imaging contrast agents, therapeutic peptides10.1007/978-1-62703-673-3_13 ↗
45. Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging10.1021/bc200613e ↗
46. A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis10.1126/scitranslmed.3010383 ↗
47. PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage10.1016/j.actbio.2015.11.017 ↗
48. Ultrasoft microgels displaying emergent platelet-like behaviours10.1038/nmat4066 ↗
49. Platelet-like particles improve fibrin network properties in a hemophilic model of provisional matrix structural defects10.1016/j.jcis.2020.05.088 ↗
50. Platelet-like particles dynamically stiffen fibrin matrices and improve wound healing outcomes10.1039/C8BM01201F ↗
51. Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in Von Willebrand disease murine models
52. Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model10.1111/jth.14552 ↗
53. Tranexamic acid (class I drug) reduced and capped gold nanoparticles as a potential hemostatic agent with enhanced performance10.1088/1361-6528/ad0f58 ↗
54. A topical alginate-based wound gel fixated with metal-based nanoparticles and tranexamic acid as a hemostatic wound healing system10.1007/s12668-023-01208-9 ↗
55. Chitosan sponges and polycaprolactone nanoparticles carrying tranexamic acid as hemostatic agent: synthesis, characterization and bioapplication10.1002/pen.26139 ↗
56. An aminocaproic acid-grafted chitosan derivative with superior antibacterial and hemostatic properties for the prevention of secondary bleeding10.1016/j.carbpol.2023.120988 ↗
57. Ceria nanoparticles synthesized with Aminocaproic acid for the treatment of subarachnoid hemorrhage10.1161/STROKEAHA.118.022631 ↗
58. Gemini dressing with both super-hydrophilicity and -hydrophobicity pursuing isolation of blood cells for hemostasis and wound healing10.1007/s42765-023-00280-w ↗
59. Safe and efficacious near superhydrophobic hemostat for reduced blood loss and easy detachment in traumatic wounds10.1021/acsami.3c12443 ↗
60. Engineering design of asymmetric halloysite/chitosan/collagen sponge with hydrophobic coating for high-performance hemostasis dressing10.1016/j.ijbiomac.2023.124148 ↗
61. Hydrophilic chitosan/graphene oxide composite sponge for rapid hemostasis and non-rebleeding removal10.1016/j.carbpol.2023.121058 ↗
62. Hemostatic strategies for traumatic and surgical bleeding10.1002/jbm.a.35052 ↗
63. Inorganic-based biomaterials for rapid hemostasis and wound healing10.1039/D2SC04962G ↗
64. Inorganic hemostats: the state-of-the-art and recent advances10.1016/j.msec.2015.09.008 ↗
65. The zeolite scene – an overview
66. Unusual zymogen activation patterns in the protein corona of Ca-zeolites10.1038/s41929-021-00654-6 ↗
67. Enhanced pro-coagulant hemostatic agents based on nanometric zeolites10.1016/j.micromeso.2016.10.020 ↗
68. Zeolite nanoparticles inhibit Aβ–fibrinogen interaction and formation of a consequent abnormal structural clot10.1021/acsami.6b10941 ↗
69. Zeolite nanoparticles for selective sorption of plasma proteins10.1038/srep17259 ↗
70. Study of clay’s mineralogy effect on mechanical properties of ceramic body using an experimental design10.1111/ijac.13983 ↗
71. Design and preclinical evaluation of chitosan/kaolin nanocomposites with enhanced hemostatic efficiency10.3390/md19020050 ↗
72. Nanoscale zerovalent iron-incorporated kaolinite for hemostatic and antibacterial applications10.1016/j.apsusc.2023.157879 ↗
73. Properties and applications of halloysite nanotubes: recent research advances and future prospects10.1016/j.clay.2015.05.001 ↗
74. Systematic studies on blood coagulation mechanisms of halloysite nanotubes-coated PET dressing as superior topical hemostatic agent10.1016/j.cej.2021.132049 ↗
75. Effect of halloysite nanotubes on the structure and function of important multiple blood components10.1016/j.msec.2017.02.022 ↗
76. Novel cellulose–halloysite hemostatic nanocomposite fibers with a dramatic reduction in human plasma coagulation time10.1021/acsami.9b04615 ↗
77. The effect of a new impregnated gauze containing bentonite and halloysite minerals on blood coagulation and wound healing10.1097/MBC.0000000000000172 ↗
78. Silica materials for medical applications10.2174/1874120700802010001 ↗
79. Silica nanoparticles induced the pre-thrombotic state in rats via activation of coagulation factor XII and the JNK-NF-κB/AP-1 pathway10.1039/C5TX00118H ↗
80. Surface-modified, zinc-incorporated mesoporous silica nanoparticles with improved antibacterial and rapid hemostatic properties10.1016/j.colsurfb.2024.114132 ↗
81. Mussel-inspired degradable antibacterial polydopamine/silica nanoparticle for rapid hemostasis10.1016/j.biomaterials.2018.06.037 ↗
82. Mesoporous silica nanoparticles carried on chitosan microspheres for traumatic bleeding control10.1016/j.ijbiomac.2019.01.039 ↗
83. Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in swine10.1097/01.TA.0000127763.90890.31 ↗
84. Multifunctional composite dressings based on Bletilla striata polysaccharide and zeolite for rapid hemostatic and accelerated wound healing10.1007/s10853-023-08306-9 ↗
85. Zeolite-fibrin clot composite as a haemostatic agent for haemophilia a10.1177/0885328219832380 ↗
86. Kaolin loaded gelatin sponges for rapid and effective hemostasis and accelerated wound healing10.1080/09205063.2024.2318086 ↗
87. Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine10.1097/TA.0b013e3181c97ef1 ↗
88. A biomimetic adhesive/kaolin material with strong adhesion, sealing, and active coagulation function for arterial hemostasis10.3390/ijms26104688 ↗
89. Halloysite nanotube microspheres connected to an electrospun nanofiber membrane for effective and riskless hemostasis10.1016/j.clay.2023.107045 ↗
90. Hemostatic electrospun nanocomposite containing poly(lactic acid)/halloysite nanotube functionalized by poly(amidoamine) dendrimer for wound healing application: in vitro and in vivo assays10.1002/mabi.202100313 ↗
91. Solution-blow spinning halloysite nanotube loaded chitosan-polyethylene oxide fibrous membrane as hemostatic dressings10.1016/j.clay.2024.107597 ↗
92. Diatomite hemostatic particles with hierarchical porous structure for rapid and effective hemostasis10.1016/j.colsurfb.2022.112809 ↗
93. Porous silica materials with different pore structures as hemostatic dressing for acute blood loss10.1016/j.micromeso.2025.113698 ↗
94. Fabrication of curcumin-loaded mesoporous silica incorporated polyvinyl pyrrolidone nanofibers for rapid hemostasis and antibacterial treatment10.1039/C6RA27319J ↗
95. Hemorrhage control in the battlefield: role of new hemostatic agents10.7205/MILMED.170.1.63 ↗
96. Polysaccharide based hemostatic strategy for ultrarapid hemostasis10.1002/mabi.201900370 ↗
97. Research progress of chitosan-based biomimetic materials10.3390/md19070372 ↗
98. Chitosan: an update on potential biomedical and pharmaceutical applications10.3390/md13085156 ↗
99. Prospects and challenges of anticancer agents’ delivery via chitosan-based drug carriers to combat breast cancer: a review10.1016/j.carbpol.2021.118192 ↗
100. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation10.1111/j.1600-0501.2004.01241.x ↗